David Berman, MD, PhD

David Berman
  • Director, Queen's Cancer Research Institute
  • 3rd Floor, Queen's Cancer Research Institute
  • Kingston, ON
  • K7L 3N6
  • Telephone: 613-533-3022
  • E-Mail: bermand@queensu.ca

Faculty Bio

Principal Investigator, CBG Division

David M. Berman, MD, PhD, Professor
Department of Pathology and Molecular Medicine
Division of Cancer Biology and Genetics
Cancer Research Institute
Queen's University

Adjunct Faculty, Departments of Pathology, Oncology, and Urology
The Johns Hopkins Medical Institutions

email: bermand(at)queensu[dot]ca

Mailing address:
10 Stuart St., QCRI 302A
Kingston, ON K7L 3N6

Office telephone: 613-533-3022


@Virchow on Twitter

David M Berman (Director of QCRI, Principal Investigator, and Professor of Pathology and Oncology) directs a research laboratory focused on high impact cancer tests for patients with prostate and bladder cancer. Laboratory members discover and evaluate novel biomarkers and therapeutic targets that can rapidly improve the lives of patients. To do this, we integrate information from massive genomic databases, our own experimental studies, and carefully curated human biospecimens. The result is a powerful approach that uses every available type of analysis. The laboratory has ongoing projects refining the use of a variety of biomarkers to guide clinical management. Recent publications can be found here.

Last Modified: 2019-06-03